These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12756393)

  • 1. Digoxin-carvedilol interactions in children.
    Ratnapalan S; Griffiths K; Costei AM; Benson L; Koren G
    J Pediatr; 2003 May; 142(5):572-4. PubMed ID: 12756393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution.
    Rusconi P; Gómez-Marín O; Rossique-González M; Redha E; Marín JR; Lon-Young M; Wolff GS
    J Heart Lung Transplant; 2004 Jul; 23(7):832-8. PubMed ID: 15261177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol therapy in pediatric patients with dilated cardiomyopathy.
    Askari H; Semizel E; Bostan OM; Cil E
    Turk J Pediatr; 2009; 51(1):22-7. PubMed ID: 19378887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol reverses elevated pulmonary vascular resistance in a child with dilated cardiomyopathy.
    Horenstein MS; Ross RD; Singh TP; Epstein ML
    Pediatr Cardiol; 2002; 23(1):100-2. PubMed ID: 11922497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.
    Skudicky D; Bergemann A; Sliwa K; Candy G; Sareli P
    Circulation; 2001 Feb; 103(8):1083-8. PubMed ID: 11222470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should pharmacotherapy of digoxin be reviewed in male patients with heart failure in the case of association with carvedilol?
    Souza FC; Neri JS; Marques EB; Barros RB; Scaramello CB
    Int J Cardiol; 2015 Jul; 191():4-6. PubMed ID: 25957928
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of dilated cardiomyopathy with carvedilol in children.
    Erdoğan I; Ozer S; Karagöz T; Celiker A; Ozkutlu S; Alehan D
    Turk J Pediatr; 2009; 51(4):354-60. PubMed ID: 19950843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of carvedilol on serum digoxin levels in heart failure: is there any gender difference?
    Baris N; Kalkan S; Güneri S; Bozdemir V; Guven H
    Eur J Clin Pharmacol; 2006 Jul; 62(7):535-8. PubMed ID: 16767433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of the drug interaction between carvedilol and dobutamine in inducing of severe hypotension in a case with acute coronary syndrome].
    Vural M
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):229. PubMed ID: 17513236
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of neurohormonal activity after treatment of children in heart failure with carvedilol.
    Giardini A; Formigari R; Bronzetti G; Prandstraller D; Donti A; Bonvicini M; Picchio FM
    Cardiol Young; 2003 Aug; 13(4):333-6. PubMed ID: 14694952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy?
    Rayan M; Tawfik M; Alabd A; Gamal A
    Anadolu Kardiyol Derg; 2011 Aug; 11(5):402-6. PubMed ID: 21712169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
    Oh PC; Kang WC; Moon J; Park YM; Kim S; Kim MG; Lee K; Ahn T; Shin EK
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):221-8. PubMed ID: 27021556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol and dose-related improvements in left ventricular function.
    Ghali JK
    Circulation; 1997 Oct; 96(8):2743-4. PubMed ID: 9355928
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.
    McPhillips JJ; Schwemer GT; Scott DI; Zinny M; Patterson D
    Drugs; 1988; 36 Suppl 6():82-91. PubMed ID: 2908306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol in heart failure: the MOCHA trial.
    Osterziel KJ
    Circulation; 1997 Oct; 96(8):2742; author reply 2743-4. PubMed ID: 9355927
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol. Results of a randomised study].
    Latini R
    Ital Heart J Suppl; 2001 Jun; 2(6):692-3. PubMed ID: 11460849
    [No Abstract]   [Full Text] [Related]  

  • 19. Intractable recurrent ventricular tachycardia in dilated cardiomyopathy controlled by a vasodilating beta blocker.
    Wright DJ; Cooke GA; Tan LB
    Heart; 1997 Jun; 77(6):581-2. PubMed ID: 9227309
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of carvedilol in infants with dilated cardiomyopathy: a preliminary report.
    Gachara N; Prabhakaran S; Srinivas S; Farzana F; Krishnan U; Shah MJ
    Indian Heart J; 2001; 53(1):74-8. PubMed ID: 11456146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.